drugset / Trial / NCT02164045

Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529

NCT02164045

Phase 1 Completed 38 enrolled ViiV Healthcare GlaxoSmithKline · collab
RandomizedCrossoverOpen-labelOther

Summary

The current food effect study is being performed to support a Phase 3 study with BMS 663068. Results from this study will inform whether patients in the upcoming Phase 3 study can be given the flexibility to dose BMS-663068 in the fasted state, if so desired.

Timeline

Start
2014-06-24
Primary completion
2014-07-25
Completion
2014-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostemsavir Other / unclassified 600 mg Oral